BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27241678)

  • 1. Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.
    Canalis E; Zanotti S
    Curr Osteoporos Rep; 2016 Aug; 14(4):126-31. PubMed ID: 27241678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hajdu-Cheney syndrome: a review.
    Canalis E; Zanotti S
    Orphanet J Rare Dis; 2014 Dec; 9():200. PubMed ID: 25491639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome.
    Vollersen N; Hermans-Borgmeyer I; Cornils K; Fehse B; Rolvien T; Triviai I; Jeschke A; Oheim R; Amling M; Schinke T; Yorgan TA
    J Bone Miner Res; 2018 Jan; 33(1):70-83. PubMed ID: 28856714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab.
    Adami G; Rossini M; Gatti D; Orsolini G; Idolazzi L; Viapiana O; Scarpa A; Canalis E
    Bone; 2016 Nov; 92():150-156. PubMed ID: 27592446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.
    Yu J; Canalis E
    J Biol Chem; 2019 Sep; 294(39):14203-14214. PubMed ID: 31371452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOTCH2 Hajdu-Cheney Mutations Escape SCF
    Fukushima H; Shimizu K; Watahiki A; Hoshikawa S; Kosho T; Oba D; Sakano S; Arakaki M; Yamada A; Nagashima K; Okabe K; Fukumoto S; Jimi E; Bigas A; Nakayama KI; Nakayama K; Aoki Y; Wei W; Inuzuka H
    Mol Cell; 2017 Nov; 68(4):645-658.e5. PubMed ID: 29149593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.
    Canalis E
    Metabolism; 2018 Mar; 80():48-56. PubMed ID: 28941602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption.
    Canalis E; Schilling L; Yee SP; Lee SK; Zanotti S
    J Biol Chem; 2016 Jan; 291(4):1538-1551. PubMed ID: 26627824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotides targeting
    Canalis E; Grossman TR; Carrer M; Schilling L; Yu J
    J Biol Chem; 2020 Mar; 295(12):3952-3964. PubMed ID: 31992595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe osteoporosis and mutation in NOTCH2 gene in a woman with Hajdu-Cheney syndrome.
    Stathopoulos IP; Trovas G; Lampropoulou-Adamidou K; Koromila T; Kollia P; Papaioannou NA; Lyritis G
    Bone; 2013 Jan; 52(1):366-71. PubMed ID: 23117206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.
    Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E
    J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct severity of phenotype in Hajdu-Cheney syndrome: a case report and literature review.
    Zeng C; Lin Y; Lu Z; Chen Z; Jiang X; Mao X; Liu Z; Lu X; Zhang K; Yu Q; Wang X; Huang Y; Liu L
    BMC Musculoskelet Disord; 2020 Mar; 21(1):154. PubMed ID: 32143606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - new data and literature review.
    Pittaway JFH; Harrison C; Rhee Y; Holder-Espinasse M; Fryer AE; Cundy T; Drake WM; Irving MD
    Orphanet J Rare Dis; 2018 Apr; 13(1):47. PubMed ID: 29618366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype variability in Hajdu-Cheney syndrome.
    Regev M; Pode-Shakked B; Jacobson JM; Raas-Rothschild A; Goldstein DB; Anikster Y
    Eur J Med Genet; 2019 Jan; 62(1):35-38. PubMed ID: 29698804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in NOTCH2 in families with Hajdu-Cheney syndrome.
    Majewski J; Schwartzentruber JA; Caqueret A; Patry L; Marcadier J; Fryns JP; Boycott KM; Ste-Marie LG; McKiernan FE; Marik I; Van Esch H; ; Michaud JL; Samuels ME
    Hum Mutat; 2011 Oct; 32(10):1114-7. PubMed ID: 21681853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice.
    Canalis E; Sanjay A; Yu J; Zanotti S
    Endocrinology; 2017 Apr; 158(4):730-742. PubMed ID: 28323963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hajdu-Cheney Syndrome: A Systematic Review of the Literature.
    Cortés-Martín J; Díaz-Rodríguez L; Piqueras-Sola B; Rodríguez-Blanque R; Bermejo-Fernández A; Sánchez-García JC
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32854429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome.
    Zhao W; Petit E; Gafni RI; Collins MT; Robey PG; Seton M; Miller KK; Mannstadt M
    Osteoporos Int; 2013 Aug; 24(8):2275-81. PubMed ID: 23389697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serpentine fibula-polycystic kidney syndrome caused by truncating mutations in NOTCH2.
    Isidor B; Le Merrer M; Exner GU; Pichon O; Thierry G; Guiochon-Mantel A; David A; Cormier-Daire V; Le Caignec C
    Hum Mutat; 2011 Nov; 32(11):1239-42. PubMed ID: 21793104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation in NOTCH2 gene first associated with Hajdu-Cheney syndrome in a Greek family: diversity in phenotype and response to treatment.
    Efstathiadou ZA; Kostoulas C; Polyzos SA; Adamidou F; Georgiou I; Kita M
    Endocrine; 2021 Jan; 71(1):208-215. PubMed ID: 32772338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.